Replies to post #138 on Incyte Corporation (INCY)

[surf1944]

8. Incyte Corporation (INCY): Focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases. Market cap at $3.24B. Price at $26.07. Performance over the last quarter at 29.25%. Over the last six months, insiders were net buyers of 4,585,074 shares, which represents about 3.63% of the company's 126.24M share float.

http://seekingalpha.com/article/711221-insiders-love-these-10-outperforming-healthcare-stocks?source=yahoo